PROTEOMIC FORUM 2019

XIII. Annual Congress of the European Proteomics Association:
From Genes via Proteins and their Interactions to Functions
March 24–28, 2019 • Potsdam, Germany

Organizational remarks

Print-File

Scientific program

Confirmed speakers

• Mohan Babu (Regina/CA)
• Marcus Bantscheff (London/GB)
• Ulrich Brandt (Nijmegen/NL)
• Matthias Gsteiger (Zurich/CH)
• Peter Hoffmann (Adelaide/AU)
• Neil Kelleher (Evanston, IL/US)
• Roland Kellner (Darmstadt/DE)
• Benedikt Kessler (Oxford/GB)
• Susan Klaeger (Cambridge/GB)
• Oliver Kohlbacher (Tübingen/DE)
• Simone Lemeer (Utrecht/NL)
• Connie Jiminez (Amsterdam/NL)
• Kathrin Lilley (Cambridge/GB)
• Johan Malmstrom (Lund/SE)
• Matthias Mann (Munich/DE)
• Lennart Martens (Ghent/BE)
• Harvey Millar (Crawley/AU)
• Jesper Velgaard Olsen (Copenhagen/DK)
• Stephen Pennington (Dublin/IR)
• Charles Pineau (Rennes/FR)
• Markus Ralser (Berlin/DE)
• Dietmar Reusch (Munich/DE)
• Henry Rodriguez (Bethesda, MD/US)
• Adelina Rogowska-Wrzesinska (Odense/DK)
• Mikhail Savitski (Heidelberg/DE)
• Matthias Selbach (Berlin/DE)
• Luis Serrano (Barcelona/ES)
• Andrea Sinz (Halle a. d. Saale/DE)
• Henning Urlaub (Göttingen/DE)
• Petra van Damme (Ghent/BE)
• Jennifer van Eyk (Los Angeles, CA/US)
• Bernd Wollscheid (Zurich/CH)
• John Yates (La Jolla, CA/US)

 

Preliminary session topics

• Human disease: Cancer, neuro, cardio, rare, immunology
• Metabolic networks
• Microbiome and microbial pathogens
• Host-pathogen interactions
• Plant and nutrition
• Protein transport and subcellular localisation
• Systems biology – Multi-omics approaches
• From data to information to knowledge to utility
• Protein-MS in clinical applications
• Antibiotic resistance mechanisms/new antimicrobial compounds
• Proteomics in cell biology
• Animals and veterinary medicine
• Proteomics in pharma – Application to biologicals, biopharmaceuticals and biosimilars
• Bioinformatics: From data analysis to integration
• Interactomics: Affinity, proximity, and spatial proteomics
• Signaling networks, pathways and pathway activity (PTMs)
• Structural proteomics/protein complexes
• Technological innovations
• Towards single cell proteomics
• Redox proteomics
• Proteogenomics and clinical applications
• New technologies
• Multi attribute monitoring, host cell protein, anti body drug conjugates, target identification
• Other topics